A typical mycobacterial infection in the patient with chronic empyema is very uncommon. We report a case of Mycobacterium intracellulare infection in a patient with chronic empyema treated successfully with surgical intervention.
Discussion
A typical mycobacterial infections usually develop in the lung, and infection outside the lung is rare. 1 Atypical mycobacterial infection in the patient with chronic empyema in particular is very uncommon. 2 The pathway of atypical mycobacterial infection to chronic empyema is unclear, but there are 2 theories about the process. 1 The first theory is development of the empyema from the lung infection. The second theory entails the development of the empyema after a minor trauma. The surgical management of M intracellulare infection with chronic empyema is not established. Yamamoto and associates 1 reported a case of Mycobacterium avium complex infection in a patient with a chronic empyema, which was treated successfully with pleuropneumonectomy. They stated that lung resection might be performed for the surgical treatment of M intracellulare infection with chronic empyema. Pleuropneumonectomy or lobectomy for chronic empyema, however, is very stressful. In our case, the M intracellulare infection was cleared from the sputum after thoracic fenestration, and therefore we performed a thoracoplasty with an intrathoracic muscle flap transposition. This surgical treatment without lung resection in cases not involving M intracellulare in the sputum is preferred because the procedure is less invasive, safer, and less stressful than surgical treatment with lung resection.
In our case, we selected a thoracoplasty with an intrathoracic muscle flap transposition. The residual lung changed into a honeycomb lung, which was unable to expand. If the residual lung had the ability to expand, air plombage would have been a better option than thoracoplasty with respect to respiratory function. 3 GRFG glue is a new biologic adhesive agent with a better sealing efficacy. GRFG glue has strong adhesive properties (almost 5 times that of fibrin glue). Several studies have reported the effectiveness of GRFG glue for the treatment of bronchial fistulas. 4, 5 Hasumi and colleagues 4 reported the clinical experience of GRFG glue for acute empyema with bronchopleural fistula. GRFG glue is a useful agent for the treatment of bronchial fistulas. H ydatid disease is common in Turkey, and it is a serious problem of worldwide importance. Because of the elastic properties of the lung, it seldom shows signs and symptoms. The cysts are generally detected on routine examinations incidentally or when they are complicated. All hydatid cysts carry a risk of rupture, which is the most common complication, and trauma is a one of its causes.
Simultaneous traumatic rupture of bilateral pulmonary hydatid cysts

1,2
Here we present a life-threatening complication of traumatic bilateral ruptured hydatid cysts causing simultaneous bilateral pneumothorax. To our knowledge, this bilateral rupture is the first case reported in the English literature.
Clinical Summary
A 20-year-old man was brought to the emergency department after a vehicle accident. He had diminished bilateral breath sounds and diffuse bronchospasm on auscultation. He was cyanotic and severely dyspneic. The computed tomographic (CT) scan of the thorax performed at the emergency department revealed bilateral pneumothorax and bilateral linear fibrotic densities in both lungs (Figure 1) .
Bilateral chest tube insertion was performed immediately. After tracheal intubation, mechanical ventilation was started because of acute respiratory failure. The patient was transferred to the intensive care unit, and the mechanical ventilation was continued for 2 days. Steroid therapy was given to relieve the bronchospasm. After the expansion of both lungs, a new CT scan was performed, showing thin-walled, air-filled cavities in bilateral lobes with collapsed membranes that were specific for ruptured hydatid cysts (Figure 2 ). Serologic test results for hydatid disease were positive.
Chest tubes were removed at the 10th and 14th days after the expansion of both lungs, and the patient was discharged on the 17th day. Albendazole (10 mg · kg Ϫ1 · d Ϫ1 ) therapy was started as soon as the rupture was diagnosed, and it was continued for 6 months. No cavitary or pleural complications were observed at the 6-month examination. 
